Research
Publications
Online Course
Cost Database
News
Events
FAQs Publications
What next after GDP-based cost-effectiveness thresholds?
Chi YL, Blecher M, Chalkidou K, Culyer A, Claxton K, Edoka I, Glassman A, Kreif N, Jones I, Mirelman AJ, Nadjib M, Morton A, Norheim OF, Ochalek J, Prinja S, Ruiz F, Teerawattananon Y, Vassall A, Winch A
Adapting health technology assessment for drugs, medical devices, and health programs: Methodological considerations from the Indian experience.
Prinja S, Jyani G, Gupta N, Rajsekar K.
Impact of National Health Mission on infant mortality in India: An interrupted time series analysis.
Prinja S, Sharma A, Nimesh R, Sharma V, Madan Gopal K, Badgaiyan N, Lakshmi P, Gupta M.
Financial burden in families of children with West syndrome.
Raithatha D, Sahu JK, Bhanudeep S, Saini L, Prinja S, Bharti B, Madaan P, Rana SK, Negi S.
Perceived effect of increased pricing on smoked tobacco products quit rates: A crosssectional study in a block of Haryana.
Rana K, Goel S, Prinja S.
Health Technology Assessment in India: Reflection and Future Roadmap.
Prinja S, Rajsekhar K, Gauba VK
Cost of scaling-up comprehensive primary health care in India: Implications for universal health coverage.
Singh D, Prinja S, Bahuguna P, Chauhan AS, Guinness L, Sharma S, Lakshmi P.
Cost analysis of pediatric intensive care: a low-middle income country perspective.
Kaur A, Jayashree M, Prinja S, Singh R, Baranwal AK.
Cost-effectiveness and budget impact analysis of facility-based screening and treatment of hepatitis C in Punjab state of India.
Chugh Y, Premkumar M, Grover GS, Dhiman RK, Teerawattanon Y, Prinja S.
Cost Effectiveness of Temozolamide for Treatment of Glioblastima Multiforme in India.
Gupta N, Prinja S, Patil V, Bahuguna P.